HomeCision

Cision

Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq

Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq

August 6, 2026

Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website

Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website

August 6, 2026

Keyera Announces 2026 Second Quarter Results

Keyera Announces 2026 Second Quarter Results

August 6, 2026

QUEBECOR INC. REPORTS CONSOLIDATED RESULTS FOR SECOND QUARTER 2026

QUEBECOR INC. REPORTS CONSOLIDATED RESULTS FOR SECOND QUARTER 2026

August 6, 2026

Avient Announces Second Quarter 2026 Results; Increases Full-Year Guidance

Avient Announces Second Quarter 2026 Results; Increases Full-Year Guidance

August 6, 2026

FS KKR Capital Corp. Announces Second Quarter 2026 Results; Declares Third Quarter 2026 Distribution of $0.44 per share

FS KKR Capital Corp. Announces Second Quarter 2026 Results; Declares Third Quarter 2026 Distribution of $0.44 per share

August 6, 2026

Scaling Autonomous Freight: Inside Pony.ai’s Robotruck Business

Scaling Autonomous Freight: Inside Pony.ai’s Robotruck Business

August 6, 2026

ABB invests in LevelTen Energy to advance clean energy procurement

ABB invests in LevelTen Energy to advance clean energy procurement

August 6, 2026

Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development

Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development

August 6, 2026

ATRenew to Report Second Quarter 2026 Financial Results on August 20, 2026

ATRenew to Report Second Quarter 2026 Financial Results on August 20, 2026

August 6, 2026

« 1 … 7 8 9 10 11 … 1,107 »